Oura Acquired | Healthcare M&A Deal

Oura has filed for an IPO, a medical devices business in Finland, for $900 million. Oura designs smart rings that function as healthcare wearables, measuring temperature, heart rate, and sleep while expanding into blood pressure detection studies. The company has FDA authorization to evaluate a high-blood-pressure feature and has built integrations with Dexcom over-the-counter glucose monitors, supporting digital health and medical devices acquisition interest. The other acquisition context includes a prior $900 million funding round and plans to develop additional health features, with the IPO following confidential SEC submission and no disclosed share count or pricing.